FDA Denies Endo (ENDP) Petition to Block Generic Forms of Opana ER
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/19/2024
- Dow, S&P inch up as AmEx gains; Netflix slump drags down Nasdaq
- Sony/Apollo bid for Paramount could be worth as much as $29 billion - Source
- Netflix Q1 earnings top estimates on blowout subscriber growth
- Stocks off two-month low as fear of Middle East escalation eases
- Gold prices rally past $2,400 on reports of Israel strikes on Iran
- Tritium DCFC Limited (DCFC): Three Australian subsidiaries were determined to be insolvent or likely to become insolvent
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- Frontier Communications (FYBR) says third party had gained unauthorized access to portions of its information technology environment
- Ibotta (IBTA) Prices 6.56M Share IPO at $88/sh
- Netflix (NFLX) Tops Q1 EPS by 77c, Offers Guidance
- Netflix, Tesla, Amex, P&G fall premarket; Paramount Global gains
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
- Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
- After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
Gabelli Sees Buying Opp in Endo Health (ENDP)
May 14, 2013 11:39 AM EDTShares of Endo Health (NASDAQ: ENDP) declined recently on news the FDA rejected Endo's Opana claims, allowing generic to remain on market. In the view of analysts at Gabelli, the sell-off is buying opportunity.
"While the FDA's decision is clearly a negative for Endo, we... More
CRT Capital Downgrades Endo Pharmaceuticals Holdings Inc (ENDP) to Fairly Valued
May 13, 2013 8:50 AM EDTCRT Capital downgraded Endo Pharmaceuticals Holdings Inc (NASDAQ: ENDP) from Buy to Fairly Valued.
For an analyst ratings summary and ratings history on Endo Pharmaceuticals Holdings Inc click here. For more ratings news on Endo... More
William Blair Downgrades Endo Pharmaceuticals Holdings Inc (ENDP) to Market Perform
May 13, 2013 8:49 AM EDTWilliam Blair downgraded Endo Pharmaceuticals Holdings Inc (NASDAQ: ENDP) from Outperform to Market Perform with a price target of $36.00 (from $43.00).
For an analyst ratings summary and ratings history on Endo Pharmaceuticals Holdings Inc... More
Jefferies Cuts Numbers on Endo Pharmaceuticals (ENDP) After 'Irrational' FDA Decision
May 13, 2013 7:25 AM EDTJefferies lowered its price target and estimates on Endo Pharmaceuticals Holdings Inc (NASDAQ: ENDP) after the FDA denied a petition to block generic Opana.
Analyst Corey Davis, Ph.D. comments, "We were wrong, FDA acted irrationally inconsistent, in our view, and will... More
Lazard Capital Downgrades Endo Pharmaceuticals Holdings Inc (ENDP) to Sell
May 13, 2013 7:09 AM EDTLazard Capital downgraded Endo Pharmaceuticals Holdings Inc (NASDAQ: ENDP) from Neutral to Sell.
For an analyst ratings summary and ratings history on Endo Pharmaceuticals Holdings Inc click here. For more ratings news on Endo... More
Endo Health Solutions Inc. (ENDP) Halted News Pending
May 10, 2013 3:40 PM EDTEndo Health Solutions Inc. (Nasdaq: ENDP) Halted News Pending... More
Endo Pharma (ENDP) trading halted on imit-up, limit-down
May 10, 2013 3:22 PM EDTEndo Pharmaceuticals Holdings (NASDAQ: ENDP) trading halted due to limit-up, limit-down trading pause.... More
Blue Ridge Capital, L.L.C. Shows New 5.98% Stake in Endo Pharmaceuticals Holdings (ENDP)
May 9, 2013 4:34 PM EDTIn a 13G filing on Endo Pharmaceuticals Holdings (NASDAQ: ENDP), John A. Griffin's hedge fund Blue Ridge Capital, L.L.C. disclosed a 5.98%, or 6,635,000 share, stake in the company. The firm did not hold shares at the end of the latest quarter ending March 31,... More
